Search Results

GPCR Podcast features leading scientists, innovators, and biotech professionals whose work is advancing Yes, we value the interactive nature of our podcast and welcome your questions or requests for clarification

Instead, receptors integrate multiple signaling outputs, temporal dynamics, and interactions with other He is also an entrepreneur and founder of biotechnology companies translating GPCR pharmacology into Early research on brown adipose tissue and thermogenesis 22:30 Translating academic discoveries into biotech

I’m currently a senior scientist at a biotech in Toronto, Canada. But as I grew up and learned more about biotechnology and the possibilities that existed, my interests And today is International Women’s Day, so we’re revealing when this podcast is being recorded. Before that, my PhD focused on carbohydrate ligands interacting with proteins. Nivedha: It was actually my first interaction with industry researchers.

His work focuses on understanding how ligands interact with receptors such as the μ-opioid and κ-opioid His broader scientific interests lie at the interface of structural biology and drug discovery, where Some studies also suggest that the galanin receptors may interact with the μ-opioid receptor. In fact, some groups believe there may even be dimeric interactions between the receptors. I can imagine myself in a biotech or pharmaceutical environment where I’m helping guide drug development

As co-founder and CEO of Keltic Pharma Therapeutics, he leads a biotechnology company developing a novel

of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development biotechnology

She received her undergraduate degree in Biotechnology from KIIT University in India.

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes Her current research focuses on how metabolic GPCRs cross-talk and interact to regulate appetite and

following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology

Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from He was the director of the French network of GPCRs (GDR-3545), currently directs the International Research

Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology

He is a leader in the study of GPCRs, biased agonism, and also on allosteric interactions between GPCRs two disciplines: Pharmacology & Toxicology and Biology & Biochemistry, a corresponding member of the International Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes An advocate for trainees at all levels, she served as Service Chairperson and Interim President of the

Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing solutions to researchers studying protein-protein interactions.

His research focuses on the structural and functional basis of GPCR–beta-arrestin interactions, combining One of them did the opposite: it disrupted the beta-arrestin–clathrin interaction and became a generic The key question that continues to fascinate us is how two isoforms of beta-arrestins are able to interact He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during

renal/hepatic pathways, and elimination 🔹 Safety First – Identifying toxicity risks and drug-drug interactions networking, mentorship, PhD resilience, COVID-19 challenges, and his aspiration to transition into biotechnology